Cargando…

Activated dendritic cells delivered in tissue compatible biomatrices induce in-situ anti-tumor CTL responses leading to tumor regression

Dendritic cell (DC) based anti-cancer immunotherapy is well tolerated in patients with advanced cancers. However, the clinical responses seen after adoptive DC therapy have been suboptimal. Several factors including scarce DC numbers in tumors and immunosuppressive tumor microenvironments contribute...

Descripción completa

Detalles Bibliográficos
Autores principales:	Verma, Vivek, Kim, Young, Lee, Min-Cheol, Lee, Jae-Tae, Cho, Sunghoon, Park, In-Kyu, Min, Jung Joon, Lee, Je Jung, Lee, Shee Eun, Rhee, Joon Haeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5129979/ https://www.ncbi.nlm.nih.gov/pubmed/27223090 http://dx.doi.org/10.18632/oncotarget.9529

Ejemplares similares

Optimal long peptide for flagellin-adjuvanted HPV E7 cancer vaccine to enhance tumor suppression in combination with anti-PD-1
por: Lee, Hye Hwa, et al.
Publicado: (2022)

Intranasal immunization with a flagellin-adjuvanted peptide anticancer vaccine prevents tumor development by enhancing specific cytotoxic T lymphocyte response in a mouse model
por: Nguyen, Chung Truong, et al.
Publicado: (2013)

Molecular characterization of vulnibactin biosynthesis in Vibrio vulnificus indicates the existence of an alternative siderophore
por: Tan, Wenzhi, et al.
Publicado: (2014)

A phase I clinical study of autologous dendritic cell therapy in patients with relapsed or refractory multiple myeloma
por: Jung, Sung-Hoon, et al.
Publicado: (2017)

Dendritic cell vaccination with a toll-like receptor agonist derived from mycobacteria enhances anti-tumor immunity
por: Vo, Manh-Cuong, et al.
Publicado: (2015)

Norovirus (NoV) specific protective immune responses induced by recombinant P dimer vaccine are enhanced by the mucosal adjuvant FlaB
por: Verma, Vivek, et al.
Publicado: (2016)

Epithelial cells as alternative human biomatrices for comet assay
por: Rojas, Emilio, et al.
Publicado: (2014)

Current Analytical Strategies for Antibody–Drug Conjugates in Biomatrices
por: Qin, Qiuping, et al.
Publicado: (2022)

Flagellin synergistically enhances anti-tumor effect of EGFRvIII peptide in a glioblastoma-bearing mouse brain tumor model
por: Choi, Jin Myung, et al.
Publicado: (2022)

More robust gut immune responses induced by combining intranasal and sublingual routes for prime-boost immunization
por: Hwang, Hye Suk, et al.
Publicado: (2018)

Mucosal vaccine adjuvants update
por: Rhee, Joon Haeng, et al.
Publicado: (2012)

Flagellin is a strong vaginal adjuvant of a therapeutic vaccine for genital cancer
por: Lee, Shee Eun, et al.
Publicado: (2015)

Lenalidomide and Programmed Death-1 Blockade Synergistically Enhances the Effects of Dendritic Cell Vaccination in a Model of Murine Myeloma
por: Vo, Manh-Cuong, et al.
Publicado: (2018)

L-Asparaginase delivered by Salmonella typhimurium suppresses solid tumors
por: Kim, Kwangsoo, et al.
Publicado: (2015)

Selection of appropriate biomatrices for studies of chronic stress in animals: a review
por: Ataallahi, Mohammad, et al.
Publicado: (2022)

Peptide-pulsed dendritic cells induce antigen-specific CTL-mediated protective tumor immunity
Publicado: (1996)

Adoptively transferred melanoma-reactive CTL primed in the presence of IL-21 and transferred with concurrent CTLA4 blockade results in enhanced CTL persistence and tumor regression
por: Yee, Cassian, et al.
Publicado: (2014)

Biodegradable biomatrices and bridging the injured spinal cord: the corticospinal tract as a proof of principle
por: Joosten, Elbert A. J.
Publicado: (2012)

ZnO Interactions with Biomatrices: Effect of Particle Size on ZnO-Protein Corona
por: Yu, Jin, et al.
Publicado: (2017)

Deglycosylation of eukaryotic-expressed flagellin restores adjuvanticity
por: Khim, Koemchhoy, et al.
Publicado: (2023)

Tumor regression is mediated via the induction of HER2(63-71)- specific CD8+ CTL activity in a 4T1.2/HER2 tumor model: no involvement of CD80 in tumor control
por: Danishmalik, Sayyed Nilofar, et al.
Publicado: (2017)

In Vivo Isolation and Characterization of Stem Cells with Diverse Phenotypes Using Growth Factor Impregnated Biomatrices
por: Grimaldi, Annalisa, et al.
Publicado: (2008)

Tetanus toxin fragment C fused to flagellin makes a potent mucosal vaccine
por: Lee, Shee Eun, et al.
Publicado: (2015)

Conditions for the generation of cytotoxic CD4(+) Th cells that enhance CD8(+) CTL-mediated tumor regression
por: Li, Kunyu, et al.
Publicado: (2016)

Egg Hatching and First Instar Falling Models of Metcalfa pruinosa (Hemiptera: Flatidae)
por: Kim, Min-Jung, et al.
Publicado: (2020)

Immunotherapy Using Dendritic Cells against Multiple Myeloma: How to Improve?
por: Nguyen-Pham, Thanh-Nhan, et al.
Publicado: (2012)

Spontaneous Regression of a Cystic Tumor in a Postpartum Woman; Is It A Cystic Lymphangioma?
por: Joo, Seung Ho, et al.
Publicado: (2007)

Interdental Papillary Reconstruction by Microtunnelling Technique Using Autologous Biomatrices—A Randomised Controlled Clinical Trial
por: Gadi, Sindhura, et al.
Publicado: (2022)

Branched Polyethylenimine-Superparamagnetic Iron Oxide Nanoparticles (bPEI-SPIONs) Improve the Immunogenicity of Tumor Antigens and Enhance Th1 Polarization of Dendritic Cells
por: Hoang, My-Dung, et al.
Publicado: (2015)

Chitinase 3-like-1, a novel regulator of Th1/CTL responses, as a therapeutic target for increasing anti-tumor immunity
por: Kim, Do-Hyun, et al.
Publicado: (2018)

The cytochrome d oxidase complex regulated by fexA is an Achilles' heel in the in vivo survival of Vibrio vulnificus
por: Tan, Wenzhi, et al.
Publicado: (2019)

Flagellin-dependent TLR5/caveolin-1 as a promising immune activator in immunosenescence
por: Lim, Jae Sung, et al.
Publicado: (2015)

Assessment of MicroRNAs Associated with Tumor Purity by Random Forest Regression
por: Nam, Dong-Yeon, et al.
Publicado: (2022)

Deimmunization of flagellin for repeated administration as a vaccine adjuvant
por: Khim, Koemchhoy, et al.
Publicado: (2021)

Induction of Peptide-specific CTL Activity and Inhibition of Tumor Growth Following Immunization with Nanoparticles Coated with Tumor Peptide-MHC-I Complexes
por: Kim, Sang-Hyun, et al.
Publicado: (2021)

The Effect of the Tumor Microenvironment and Tumor-Derived Metabolites on Dendritic Cell Function
por: Lee, Jun-Ho, et al.
Publicado: (2020)

A Fusion Protein of Derp2 Allergen and Flagellin Suppresses Experimental Allergic Asthma
por: Tan, Wenzhi, et al.
Publicado: (2018)

Oncologic and obstetric outcomes of conservative surgery for borderline ovarian tumors in women of reproductive age
por: Lee, Se Yun, et al.
Publicado: (2017)

Evolution of the Tumor Microenvironment toward Immune-Suppressive Seclusion during Brain Metastasis of Breast Cancer: Implications for Targeted Therapy
por: Noh, Myung-Giun, et al.
Publicado: (2021)

Linear Tumor Regression of Rectal Cancer in Daily MRI during Preoperative Chemoradiotherapy: An Insight of Tumor Regression Velocity for Personalized Cancer Therapy
por: Sung, Soo-Yoon, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_1r21624glecuofdh8m66vgskr4